Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Koiwai Milk Products is a prominent Japanese dairy and functional food company, operating as a key subsidiary of Kirin Holdings. The company leverages advanced fermentation biotechnology to develop health-oriented dairy products, most notably those incorporating the proprietary Lactococcus lactis strain Plasma (LC-Plasma). This specific probiotic strain is clinically recognized for its ability to activate plasmacytoid dendritic cells, providing a unique mechanism for immune system support. Koiwai's business model integrates traditional high-quality dairy production with modern life science research to address consumer needs in the "Food as Medicine" sector. Their portfolio includes milk, yogurt, and cheese products distributed widely across the Japanese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Koiwai Milk Products.